FDA begins technology overhaul in preparation for tsunami of data and real-world evidence

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

To keep up with an increasingly data-rich health ecosystem, FDA is implementing a multi-year strategic plan to modernize its technology infrastructure—boosting cloud capabilities and building sophisticated data analytics for using real-world evidence to support regulatory decisions.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Senior Editor
Table of Contents

YOU MAY BE INTERESTED IN

Patients treated with first-line immunotherapy for advanced non-small cell lung cancer showed similar results in terms of survival, progression-free survival, and treatment duration, regardless of race or ethnicity, even with differences in income and insurance, a study published in the Journal of the National Comprehensive Cancer Network showed.
Matthew Bin Han Ong
Senior Editor

Login